Company Cash Funds: Omeros Corp. (OMER)

Corporate emblem and logo of omeros.com (OMER)

Omeros Corporation focuses on the independent development of its pipeline, a trend reflected in the dynamics of its operating cash flow. The business relies on patent protection for its molecules, which eliminates generic competition, and demonstrates immunity to macroeconomic GDP fluctuations. The 0.09 indicator reflects the most recent value of the metric, allowing for an assessment of the company's level of financial autonomy and the efficiency of its cash reserve management.

OMER - Omeros Company Cash Volume over the range 07/04/2022 - 11/21/2026

Analytical breakdowns and data insights for company omeros.com (OMER)

- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
Analysis of all company metrics:OMER omeros.com
Brand item of Omeros Corporation

Stress testing assets requires liquidity analysis to assess business resilience to macroeconomic shocks. Omeros Corporation (OMER) relies on significant pricing power driven by its unique research into MASP-2 inhibitors. Free cash flow dynamics reflect the balance between capital depreciation during inflation and efficient reinvestment in growth. This indicator measures the rate of change in reserves, determining the biotech's financial autonomy.

Who Omeros Corporation competes with

Company Cash Volume BIIB|Company Cash Funds NBIX (Neurocrine Biosciences)|Company Cash Funds Regencell Bioscience Ltd RGC|AXSM (Axsome Therapeutics, Inc.) - Company Total Cash Volume|ACADIA Corp - Company Cash Volume|Company Cash Reserve Xenon Pharmaceuticals|VKTX (Viking Therapeutics Corp) - Company Cash on Hand|Supernus Pharmaceuticals (SUPN) - Company Cash Volume|CPRX (Catalyst Pharma) - Company Cash Volume|DNLI (Denali Therapeutics Inc.) - Company Total Cash Amount|Company Cash Volume HRMY|Biohaven Corp - Company Cash and Cash Equivalents|Company Cash Volume AMLX (amylyx.com)|Company Liquid Assets Trevi Therapeutics, Inc. (TRVI)|Praxis Corp - Company Cash Volume|Company Cash Reserve Anavex|CBLL (CeriBell Inc) - Company Cash on Hand|Company Cash and Cash Equivalents PRTA|Company Cash Funds Alector Inc.|Company Cash Reserve Annexon, Inc. ANNX|Company Cash Funds Neurogene (NGNE)|Company Liquid Assets AC Immune S.A.|Company Cash Volume VYGR (Voyager Therapeutics Inc)|Company Cash Balance NMRA|scilexholding.com - Company Cash Volume|TVGN (tevogen.com) - Company Cash and Cash Equivalents|ACOG: Company Cash Volume|CGTX: Company Total Cash Amount|Company Cash Funds Inhibikase Therapeutics|Company Cash and Cash Equivalents SAVA (Cassava)|Company Cash Funds Assertio Therapeutics (ASRT)|Coya Therapeutics - Company Cash and Cash Equivalents|VistaGen Therapeutics, Inc. - Company Cash on Hand|ovidrx.com (OVID) - Company Cash Reserve|ABOS: Company Cash on Hand|Company Cash Reserve CervoMed Inc|alteritytherapeutics.com (ATHE) - Company Cash Funds|Company Cash on Hand Clene Nanomedicine|Company Cash on Hand PEPG|Company Cash Reserve Jupiter Neurosciences JUNS|Company Cash Funds Relmada (RLMD)|Company Liquid Assets Annovis Bio, Inc.|Company Cash Volume GRCE (Grace Tx)|Firefly Neuroscience, Inc (AIFF) - Company Cash Reserve|KLTO - Company Cash Funds|Company Cash Reserve NeuroSense Therapeutics Ltd|RVPH: Company Cash Volume|MetaVia, Inc. (MTVA) - Company Cash Volume|Company Cash Funds NeurAxis|Company Cash Volume heliusmedical.com|Company Cash on Hand PASG (Passage Bio Inc.)|Neuphoria Therapeutics - Company Cash and Cash Equivalents|Minerva Neurosciences Corp - Company Cash on Hand|Company Cash Balance ATHA|ADXN - Company Cash Funds|Company Cash Reserve Alzamend Neuro Inc.|Cyclerion Therapeutics (CYCN) - Company Cash Funds|Company Cash and Cash Equivalents PTIX|KTTA (pasitheaclinics.com) - Company Cash Volume|CRGT (cortigent.com) - Company Total Cash Amount|Company Cash Volume ATXI|Company Cash Funds BCLI (Brainstorm Cell)|Company Cash Volume CARA (Cara Therapeutics Inc)|Company Cash Balance CHRO|Eliem Therapeutics Inc. - Company Cash Volume|ITCI - Company Cash Volume|Longboard Pharma (LBPH) - Company Cash Funds|Company Cash on Hand Marinus Pharmaceuticals|Company Cash Funds NKGen|Company Cash Volume NeuroBo Pharmaceuticals, Inc.|Company Cash Volume SAGE|Synaptogenix, Inc - Company Cash and Cash Equivalents|Company Cash Funds Trevena TRVN|Company Cash Position Vigil Neuroscience|Anew Medical Inc. - Company Cash Volume|Company Liquid Assets Cerevel Therapeutics, Inc. CERE